Most progress in cancer treatment by Novartis/Mariana by end of 2024

Novartis achieves clinical milestone with Mariana's drug by May 2024?

Regulatory setback for Novartis/Mariana by May 2024?

Integration status of Mariana Oncology into Novartis by May 2024

Impact on Novartis stock price by end of 2024

PTC518 FDA Approval for Huntington's by End of 2025?

Will PTC518 receive FDA approval for Huntington's disease by end of 2025?

Will Monte Rosa's market cap double by end of 2025 following Novartis deal?

Will Pfizer's Ibrance sales exceed $5 billion annually by end of 2025?

Will Ibrance receive FDA approval for expanded use in HR+, HER2+ metastatic breast cancer by end of 2025?

Will PTC518 enter Phase 3 trials for Huntington's disease by mid-2025?

What will be the total revenue generated for PTC from PTC518 by end of 2025?

Asciminib (Scemblix) market share over 30% in US by end of 2025?

Asciminib (Scemblix) major molecular response rate by end of 2025?

Monte Rosa stock price increases by 50% after Novartis deal by March 2025?

Will Monte Rosa receive first milestone payment from Novartis by end of 2025?

Will Monte Rosa receive a milestone payment from Novartis by end of 2024?

Will Novartis announce another targeted protein degradation partnership by Oct 28, 2025?

Will Monte Rosa's stock price rise by 20% or more by Jan 31, 2025?

Market share of Baiyu's cancer drug in Novartis' oncology portfolio by 2026?

Total milestone payments made by Novartis to Baiyu by end of 2025?

Will Kisqali receive full EU approval for HR+/HER2- early breast cancer by end of 2025?

Will Novartis make the first milestone payment to Baiyu by end of 2025?

Will Novartis receive FDA approval for Baiyu's cancer drug by end of 2025?

Which major pharmaceutical company will Generate:Biomedicines announce a new partnership with by September 30, 2025?

Will Generate:Biomedicines' cash balance exceed $400 million by March 31, 2025?

Will Novartis make an additional milestone payment to Generate:Biomedicines by December 31, 2024?

Will Generate:Biomedicines initiate a clinical trial for a new protein therapeutic from the Novartis partnership by March 31, 2025?

How many new prescriptions for Kisqali will be issued by the end of Q2 2025?

Will Novartis report revenue growth in 2025 due to Kisqali approval?

How will Novartis' stock performance compare to its competitors by the end of Q1 2025?

Will Novartis's stock price increase by more than 10% by the end of 2024 due to Kisqali's expanded approval?

Will Kisqali be approved by the EMA for early-stage breast cancer by the end of 2024?

What will be the percentage increase in Kisqali prescriptions in the US by the end of Q1 2025?

Will Travere Therapeutics' stock price increase by 20% or more by the end of 2024?

Will FILSPARI achieve $500 million in sales by the end of 2024?

By when will Siemens Healthineers complete the operational integration of Novartis' Molecular Imaging Business?

Will Siemens Healthineers complete the acquisition of Novartis' Molecular Imaging Business by December 31, 2024?

Damages awarded to Lacks' family in lawsuit against Novartis and Viatris by end of 2024?

Novartis reaches settlement with Lacks' family over HeLa cells by end of 2024?

Lacks' family wins lawsuit against Novartis and Viatris over HeLa cells by end of 2024?

Outcome of Lacks' family lawsuit against Novartis over HeLa cells by end of 2024?

Novartis increases market share in radiopharmaceuticals by end of 2024?

Will Ibrance surpass Kisqali in market share for HR+, HER2+ metastatic breast cancer by end of 2025?

Which region will approve Ibrance for expanded use in HR+, HER2+ metastatic breast cancer by end of 2025?

Which company will announce the next breakthrough in HR+, HER2+ metastatic breast cancer by end of 2025?

What will be the percentage increase in Ibrance's market share for HR+, HER2+ metastatic breast cancer by end of 2025?

PTC518 Global Market Share in First Year Post-Launch?

PTC518 Phase 3 Clinical Trials Start by End of 2024?

PTC518 Milestone Payments from Novartis by End of 2025?

Top Sales Region for PTC518 in First Two Years?

Outcome of PTC518 Phase 2 Trials by End of 2024?

What will be PTC518's US market share in Huntington's disease treatments by 2026?

Will PTC and Novartis achieve first milestone payment for PTC518 by end of 2024?

How many additional partnerships will PTC form for PTC518 by end of 2025?

Health Canada approval for Asciminib (Scemblix) by March 31, 2025?

Main competitor to Asciminib (Scemblix) in US by end of 2025?

Next region to approve Asciminib (Scemblix) after US by end of 2025?

Major adverse effects reported for Asciminib (Scemblix) in US by October 2025?

Level of milestone payments achieved by Monte Rosa from Novartis by end of 2025?

Monte Rosa receives first milestone payment from Novartis by end of 2025?

MRT-6160 progresses to Phase 2 trials by end of 2025?

Monte Rosa market cap levels following Novartis deal by end of 2025?

Success levels of MRT-6160 in Phase 1 trials by end of 2025?

Will MRT-6160 progress to Phase 2 trials by end of 2025?

What financial impact will MRT-6160 have on Novartis by end of 2025?

What will be the next major strategic move by Monte Rosa by end of 2025?

Which significant milestone will MRT-6160 achieve by end of 2025?

Monte Rosa's market position in protein degradation by end of 2025?

Total payments by Novartis to Monte Rosa by end of 2025?

How many major partnerships will Monte Rosa sign by Oct 28, 2025?

Which region will see the first launch of Baiyu's cancer drug by Novartis by end of 2025?

What will be the outcome of the first clinical data from the Novartis and Generate:Biomedicines partnership reported by December 31, 2024?

What will be the first disease area targeted by the Novartis and Generate:Biomedicines partnership announced by June 30, 2025?

Will Kisqali's market share in the breast cancer treatment market increase by the end of Q1 2025?

How will competitors respond to Kisqali's FDA approval by the end of 2024?

Will Kisqali be included in new clinical guidelines for breast cancer treatment by the end of 2024?

What will be the overall market share of Kisqali in the HR+/HER2- breast cancer drug market by the end of 2024?

Which region will have the highest increase in Kisqali sales by the end of 2024?

Will Kisqali's approval be expanded to additional stages of breast cancer by the end of 2024?

What will be Travere Therapeutics' stock price at the end of 2024?

Who will be the first major competitor to launch a non-immunosuppressive IgA nephropathy treatment after FILSPARI's approval?

Will Novartis announce a new IgA nephropathy treatment by the end of 2024?

Which company will have the highest market share in IgA nephropathy treatments by the end of 2024?

What will be the revenue impact on Siemens Healthineers by the end of 2025 due to the acquisition of Novartis' Molecular Imaging Business?

Will Siemens Healthineers' stock price increase by more than 5% within one month of completing the acquisition of Novartis' Molecular Imaging Business?

Will the acquisition of Novartis' Molecular Imaging Business by Siemens Healthineers receive regulatory approval by March 31, 2025?

How much will Siemens Healthineers' market share in the molecular imaging sector increase by the end of 2025 due to the acquisition of Novartis' Molecular Imaging Business?

Viatris reaches settlement with Lacks' family over HeLa cells by end of 2024?

Outcome of Lacks' family lawsuit against Viatris over HeLa cells by end of 2024?